Annual accounts
Total Exemption Full accounts
30/09/2026Filing deadline
Made up to 31/05/2025Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/05/2025
RE-VANA THERAPEUTICS LTD
Active- NI638333Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Catalyst - Concourse 3, 15 Queens Road, Belfast BT3 9DT
- Classification (3 SIC codes)
- Research and experimental development on biotechnology (72.11 - SIC 2007)Other research and experimental development on natural sciences and engineering (72.19 - SIC 2007)Other professional scientific and technical activities n.e.c. (74.90/9 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 15/04/2026View PDF (3 pages)
Confirmation statement made on 2026-03-14 with no updates
- 26/03/2026View PDF (1 pages)
Registered office address changed from 63 University Road Belfast BT7 1NF Northern Ireland to Catalyst - Concourse 3 15 Queens Road Belfast BT3 9DT on 2026-03-26
- 17/02/2026View PDF (1 pages)
Previous accounting period shortened from 2026-05-31 to 2025-12-31
- 12/02/2026View PDF (11 pages)
Total exemption full accounts made up to 2025-05-31
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 5 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 14/03/2026
- Last statement dated
- 31/05/2025
Financial performance
The latest figures RE-VANA THERAPEUTICS LTD filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£3.09M2025
-46.93%vs 20242024: £5.82M
Total Assets
£3.46M2025
-42.19%vs 20242024: £5.98M
Cash in Bank
£2.95M2025
-46.67%vs 20242024: £5.53M
Total Liabilities
£370.75K2025
126.54%vs 20242024: £163.66K
Employees
72025
+4vs 20242024: 3
Of the 4 measures with an earlier filing to compare against, 1 rose and 3 fell. Net assets moved furthest, down 46.93% on 2024. See the full financial analysis for RE-VANA THERAPEUTICS LTD.
The full financial record
Four ways through RE-VANA THERAPEUTICS LTD's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · -23% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 7 | +4 |
| 2024 | 3 | 0 |
| 2023 | 3 | +3 |
| 2022 | 0 | -1 |
| 2021 | 1 | – |
Reported employee count increased from 1 in 2021 to 7 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
12Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 09/05/2016–28/11/2022 | 2 | |
| Director | 29/09/2017–28/11/2022 | 2 | |
| Director | 24/11/2017–17/11/2021 | 9 | |
| Director | 24/11/2017–29/05/2020 | 28 | |
| Director | 16/05/2016–15/05/2017 | 7 | |
| Director | 29/07/2016–28/11/2022 | 0 | |
| Director | 16/05/2016–07/12/2017 | 1 | |
| Director | 28/11/2022–Present | 0 | |
| Director | 29/05/2020–Present | 0 | |
| Director | 20/03/2020–Present | 0 | |
| Director | 13/05/2017–Present | 0 | |
| Director | 17/11/2021–Present | 0 |
Persons with significant control
2Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 24/11/2017–Present | 0 | |
| 16/05/2016–13/12/2017 | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 18 Since 29/11/2022
- Last 12 months
- 4 +2 vs the year before
- Most recent filing
- 15/04/2026 5 months ago
What changed in the last year
- Confirmation statementLatest 15/04/2026
- Registered officeLatest 26/03/2026
- Accounts filedLatest 12/02/2026
Filing timeline
- 15/04/2026View PDF (3 pages)
Confirmation statement made on 2026-03-14 with no updates
- 26/03/2026View PDF (1 pages)
Registered office address changed from 63 University Road Belfast BT7 1NF Northern Ireland to Catalyst - Concourse 3 15 Queens Road Belfast BT3 9DT on 2026-03-26
- 17/02/2026View PDF (1 pages)
Previous accounting period shortened from 2026-05-31 to 2025-12-31
- 12/02/2026View PDF (11 pages)
Total exemption full accounts made up to 2025-05-31
- 27/03/2025View PDF (9 pages)
Confirmation statement made on 2025-03-14 with updates
- 26/02/2025View PDF (11 pages)
Total exemption full accounts made up to 2024-05-31
- 30/05/2024View PDF (11 pages)
Unaudited abridged accounts made up to 2023-05-31
- 19/03/2024View PDF (8 pages)
Confirmation statement made on 2024-03-14 with updates
- 01/12/2023View PDF (3 pages)
Statement of capital following an allotment of shares on 2023-11-29
- 27/06/2023View PDF (8 pages)
Confirmation statement made on 2023-06-27 with updates
- 22/02/2023View PDF (3 pages)
Micro company accounts made up to 2022-05-31
- 07/12/2022View PDF (23 pages)
Memorandum and Articles of Association
Showing 12 of 18 filings
See when the next accounts and confirmation statement are due
Similar companies
84 UK companies are similar to RE-VANA THERAPEUTICS LTD, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
ELIPTICA LIMITED
Active2 Communications Road, Greenham Business Park, Newbury, Berkshire RG19 6AB
- Activity
- Research and experimental development on biotechnology
- Company no.
- 14041502
- Incorporated
- 12/04/2022
- Employees
- 5
LAMBDA ENERGY LTD
ActiveAllia Future Business Centre, Kings Hedges Road, Cambridge CB4 2HY
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11246890
- Incorporated
- 10/03/2018
- Employees
- 5
AKL RESEARCH & DEVELOPMENT LIMITED
ActiveThe Lexicon Second Floor, Mount Street, Manchester M2 5NT
- Activity
- Research and experimental development on biotechnology
- Company no.
- 08699350
- Incorporated
- 20/09/2013
- Employees
- 5
ADDIBLE LTD
ActiveSpitfire House 19 Falcon Court, Preston Farm Industrial Estate, Stockton-On-Tees TS18 3TU
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 12633636
- Incorporated
- 30/05/2020
- Employees
- 7
AMPERSAND HEALTH LIMITED
Active76 Portland Place, London W1B 1NT
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11584266
- Incorporated
- 24/09/2018
- Employees
- 5
About RE-VANA THERAPEUTICS LTD
A short description of the company, written from its Companies House record.
RE-VANA THERAPEUTICS LTD is a private limited company registered in the United Kingdom, based in Catalyst - Concourse 3, 15 Queens Road, Belfast BT3 9DT. Companies House classifies its business as Research and experimental development on biotechnology, one of 3 SIC classifications on its record. It has been on the register for 10 years 4 months.
The register currently records it as active. Its 2025 accounts report net assets of £3.09M and 7 employees.
RE-VANA THERAPEUTICS LTD: frequently asked questions
Answered from this company's own registry record and filed figures.
What does RE-VANA THERAPEUTICS LTD do?
Companies House records RE-VANA THERAPEUTICS LTD under 3 registered business activities: Research and experimental development on biotechnology (72.11 - SIC 2007), Other research and experimental development on natural sciences and engineering (72.19 - SIC 2007) and Other professional scientific and technical activities n.e.c. (74.90/9 - SIC 2007).
Is RE-VANA THERAPEUTICS LTD still active?
RE-VANA THERAPEUTICS LTD is recorded as active on the Companies House register, and has been on it since 09/05/2016.
What are RE-VANA THERAPEUTICS LTD's latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £3.09M, total assets of £3.46M, cash in bank of £2.95M and total liabilities of £370.75K.
When did RE-VANA THERAPEUTICS LTD last file with Companies House?
The most recent document on the record is dated 15/04/2026: Confirmation statement made on 2026-03-14 with no updates, 5 months ago.
When are RE-VANA THERAPEUTICS LTD's next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs RE-VANA THERAPEUTICS LTD?
Companies House lists 12 officers (5 currently in post) and 2 people with significant control (1 current).